U.S. Remote Patient Monitoring Market - Industry Outlook & Forecast 2022-2027

Description

List of Tables

Arizton's report considers the present scenario of the U.S. remote patient monitoring market and its market dynamics for 2022-2027. It covers a detailed overview of several market growth enablers, restraints, and trends. The study covers both the demand and supply sides of the market. It also profiles and analyses leading companies and several other prominent companies operating in the market.

The US remote patient monitoring market is expected to grow at a CAGR of 12.63%.

MARKET GROWTH ENABLERS

Increasing Innovations in Wearable Medical Devices
Growing Use of Mobile Technologies & Smart Devices for Remote Patient Monitoring
Aging Population Vulnerable to Chronic Diseases

U.S. REMOTE PATIENT MONITORING MARKET SEGMENTATION

The Devices and Software segment accounts for the largest share than that of the Services segment in the U.S. remote patient monitoring market. The increasing adoption of wearable medical devices, technological advancements in IoT, the rise in the adoption of home healthcare systems are expected to boost the adoption of device & software segment in the remote patient monitoring market.

The hospitals and specialty clinics accounted for the largest share in the U.S. remote patient monitoring market and the Homecare setting is anticipated to be the fastest-growing end-user. With the increased demand for hospital beds and the challenge of delivering care with staff shortages, some health care centers prefer remote patient monitoring solutions. Moreover, technological advancements have made it viable to monitor patients remotely while at home or in skilled nursing facilities.

Segmentation by Component

Devices & Software
Services

Segmentation by Devices

Cardiac Monitoring Devices
Respiratory Monitoring Devices
Blood Glucose Monitors (Includes CGM)
Fetal & Neonatal Monitoring Devices
Other Rpm Devices

Segmentation by Application

Cardiology Remote Patient Monitoring
Pulmonology Remote Patient Monitoring
Endocrinology Remote Patient Monitoring*
Others

Segmentation by End-User

Hospitals & Specialty Clinics
Homecare Settings
Ambulatory Surgical Centers
Long Term & Acute Care Centers
Other End Users

COMPETITIVE LANDSCAPE

Manufacturers and providers are rapidly approaching the RPM technology to limit costs, improve patient outcomes, and cut down on using more expensive services for a share of this growing market.

The major competitors in the industry are focusing their efforts on reducing the size of remote patient monitoring devices. These companies are also attempting to increase their market share by launching new goods and forming collaborations with other industry participants. As a result, these factors are expected to increase the remote patient monitoring market size.

Key Vendors

Medtronic
Philips Healthcare
ResMed

Other Prominent Vendors

100-Plus
A&D Company
Abbott
AltumView Syste
BIOTRONIK
Boston Scientific
Bardy Diagnostics
Cardiomo Care
Cardiologs
Dragerwerk
Hoffmann-La Roche
GE Healthcare
GrandCare Systems
Honeywell International
iHealthUnifiedcare
Qardio
MedM
Masimo Corporation
Medopad
Nihon Kohden
Omron Healthcare
OSPLabs
Resideo Technologies
Smiths Medical
Spacelabs Healthcare
Senseonics
TeleMedCare
VitalConnect
Vitls
Modivcare
Hill-Rom
Vivify Health
ACL Digital
Dexcom
iRhythm Technologies
Vivalink
Biobeat
CareValidate
Biofourmis
CAREMINDr
Datos Health

Product Code: ARZ220321

1 RESEARCH METHODOLOGY

2 RESEARCH OBJECTIVES

3 RESEARCH PROCESS

4 SCOPE & COVERAGE

4.1 MARKET DEFINITION
- 4.1.1 INCLUSIONS
- 4.1.2 EXCLUSIONS
- 4.1.3 MARKET ESTIMATION CAVEATS
4.2 BASE YEAR
4.3 SCOPE OF THE STUDY
- 4.3.1 MARKET SEGMENTATION BY COMPONENT
- 4.3.2 MARKET SEGMENTATION BY APPLICATION
- 4.3.3 MARKET SEGMENTATION BY END-USER
- 4.3.4 MARKET SEGMENTATION BY GEOGRAPHY

5 REPORT ASSUMPTIONS & CAVEATS

5.1 KEY CAVEATS
5.2 CURRENCY CONVERSION
5.3 MARKET DERIVATION

6 MARKET AT A GLANCE

7 INTRODUCTION

7.1 OVERVIEW

8 MARKET OPPORTUNITIES & TRENDS

8.1 TECHNOLOGICAL ADVANCEMENTS, IMPROVED CONNECTIVITY, & REMOTE MONITORING
8.2 TELEMEDICINE USHERING NEW OPPORTUNITIES FOR REMOTE MONITORING
8.3 INCREASING ROLE OF INTERNET OF THINGS (IOT) IN REMOTE MONITORING & HEALTHCARE

9 MARKET GROWTH ENABLERS

9.1 INCREASING INNOVATIONS IN WEARABLE MEDICAL DEVICES
9.2 GROWING USE OF MOBILE TECHNOLOGIES & SMART DEVICES FOR REMOTE PATIENT MONITORING
9.3 AGING POPULATION VULNERABLE TO CHRONIC DISEASES
9.4 GROWING USE OF RPM TO MONITOR & IMPROVE PATIENT ENGAGEMENT

10 MARKET GROWTH RESTRAINTS

10.1 REGULATORY VARIATIONS ACROSS COUNTRY
10.2 LACK OF DATA ACCURACY

11 MARKET LANDSCAPE

11.1 MARKET OVERVIEW
11.2 MARKET SIZE & FORECAST
- 11.2.1 MARKET SHARE BY COMPONENT
- 11.2.2 MARKET SHARE BY DEVICES & SOFTWARE
- 11.2.3 MARKET SHARE BY APPLICATION
- 11.2.4 MARKET SHARE BY END-USER
11.3 FIVE FORCES ANALYSIS
- 11.3.1 THREAT OF NEW ENTRANTS
- 11.3.2 BARGAINING POWER OF SUPPLIERS
- 11.3.3 BARGAINING POWER OF BUYERS
- 11.3.4 THREAT OF SUBSTITUTES
- 11.3.5 COMPETITIVE RIVALRY

12 COMPONENT

12.1 MARKET SNAPSHOT & GROWTH ENGINE

13 DEVICES & SOFTWARE

13.1 MARKET SNAPSHOT & GROWTH ENGINE
13.2 MARKET OVERVIEW
- 13.2.1 MARKET SIZE & FORECAST
13.3 CARDIAC MONITORING DEVICES
- 13.3.1 MARKET OVERVIEW
- 13.3.2 MARKET SIZE & FORECAST
- 13.3.3 ELECTROCARDIOGRAPHS (ECGS): MARKET OVERVIEW
- 13.3.4 MARKET SIZE & FORECAST
- 13.3.5 CARDIAC MONITORS: MARKET OVERVIEW
- 13.3.6 MARKET SIZE & FORECAST
- 13.3.7 BLOOD PRESSURE MONITORS: MARKET OVERVIEW
- 13.3.8 MARKET SIZE & FORECAST
- 13.3.9 OTHERS: MARKET OVERVIEW
- 13.3.10 MARKET SIZE & FORECAST
13.4 RESPIRATORY MONITORING DEVICES
- 13.4.1 MARKET OVERVIEW
- 13.4.2 MARKET SIZE & FORECAST
- 13.4.3 APNEA MONITORS: MARKET OVERVIEW
- 13.4.4 MARKET SIZE & FORECAST
- 13.4.5 PULSE OXIMETERS: MARKET OVERVIEW
- 13.4.6 MARKET SIZE & FORECAST
- 13.4.7 OTHER RESPIRATORY MONITORING DEVICES: MARKET OVERVIEW
- 13.4.8 MARKET SIZE & FORECAST
13.5 BLOOD GLUCOSE MONITORS
- 13.5.1 MARKET OVERVIEW
- 13.5.2 MARKET SIZE & FORECAST
13.6 FETAL & NEONATAL MONITORING DEVICES
- 13.6.1 MARKET OVERVIEW
- 13.6.2 MARKET SIZE & FORECAST
13.7 OTHER RPM DEVICES
- 13.7.1 MARKET OVERVIEW
- 13.7.2 MARKET SIZE & FORECAST

14 SERVICES

14.1 MARKET OVERVIEW
14.2 MARKET SIZE & FORECAST

15 APPLICATION

15.1 MARKET SNAPSHOT & GROWTH ENGINE
15.2 MARKET OVERVIEW
15.3 CARDIOLOGY
- 15.3.1 MARKET OVERVIEW
- 15.3.2 MARKET SIZE & FORECAST
15.4 PULMONOLOGY
- 15.4.1 MARKET OVERVIEW
- 15.4.2 MARKET SIZE & FORECAST
15.5 ENDOCRINOLOGY
- 15.5.1 MARKET OVERVIEW
- 15.5.2 MARKET SIZE & FORECAST
15.6 OTHERS
- 15.6.1 MARKET OVERVIEW
- 15.6.2 MARKET SIZE & FORECAST

16 END-USER

16.1 MARKET SNAPSHOT & GROWTH ENGINE
16.2 MARKET OVERVIEW
16.3 HOSPITALS & SPECIALTY CLINICS
- 16.3.1 MARKET OVERVIEW
- 16.3.2 MARKET SIZE & FORECAST
16.4 HOMECARE SETTINGS
- 16.4.1 MARKET OVERVIEW
- 16.4.2 MARKET SIZE & FORECAST
16.5 AMBULATORY SURGICAL CENTERS
- 16.5.1 MARKET OVERVIEW
- 16.5.2 MARKET SIZE & FORECAST
16.6 LONG-TERM & ACUTE CARE CENTERS
- 16.6.1 MARKET OVERVIEW
- 16.6.2 MARKET SIZE & FORECAST
16.7 OTHERS
- 16.7.1 MARKET OVERVIEW
- 16.7.2 MARKET SIZE & FORECAST

17 COMPETITIVE LANDSCAPE

17.1 COMPETITION OVERVIEW BY DEVICES & SOFTWARE
- 17.1.1 MEDTRONIC
- 17.1.2 PHILIPS HEALTHCARE
- 17.1.3 RESMED
17.2 COMPETITION OVERVIEW BY SERVICES
- 17.2.1 MEDM
- 17.2.2 IHEALTHUNIFIEDCARE
- 17.2.3 QARDIO

18 KEY VENDORS

18.1 MEDTRONIC
- 18.1.1 BUSINESS OVERVIEW
- 18.1.2 PRODUCT OFFERING
18.2 PHILIPS HEALTHCARE
- 18.2.1 BUSINESS OVERVIEW
- 18.2.2 PRODUCT OFFERING
18.3 RESMED
- 18.3.1 BUSINESS OVERVIEW
- 18.3.2 PRODUCT OFFERING

19 OTHER PROMINENT VENDORS

19.1 100-PLUS
- 19.1.1 BUSINESS OVERVIEW
- 19.1.2 PRODUCT OFFERINGS
19.2 A&D COMPANY
- 19.2.1 BUSINESS OVERVIEW
- 19.2.2 PRODUCT OFFERINGS
19.3 ABBOTT
- 19.3.1 BUSINESS OVERVIEW
- 19.3.2 PRODUCT OFFERINGS
19.4 ALTUMVIEW SYSTEMS
- 19.4.1 BUSINESS OVERVIEW
- 19.4.2 PRODUCT OFFERINGS
19.5 BIOTRONIK
- 19.5.1 BUSINESS OVERVIEW
- 19.5.2 PRODUCT OFFERING
19.6 BOSTON SCIENTIFIC
- 19.6.1 BUSINESS OVERVIEW
- 19.6.2 PRODUCT OFFERINGS
19.7 BARDY DIAGNOSTICS
- 19.7.1 BUSINESS OVERVIEW
- 19.7.2 PRODUCT OFFERINGS
19.8 CARDIOMO CARE
- 19.8.1 BUSINESS OVERVIEW
- 19.8.2 PRODUCT OFFERINGS
19.9 CARDIOLOGS
- 19.9.1 BUSINESS OVERVIEW
- 19.9.2 PRODUCT OFFERINGS
19.10 DRAGERWERK AG
- 19.10.1 BUSINESS OVERVIEW
- 19.10.2 PRODUCT OFFERINGS
19.11 F. HOFFMANN-LA ROCHE
- 19.11.1 BUSINESS OVERVIEW
- 19.11.2 PRODUCT OFFERINGS
19.12 GE HEALTHCARE
- 19.12.1 BUSINESS OVERVIEW
- 19.12.2 PRODUCT OFFERINGS
19.13 GRANDCARE SYSTEMS
- 19.13.1 BUSINESS OVERVIEW
- 19.13.2 PRODUCT OFFERINGS
19.14 HONEYWELL INTERNATIONAL
- 19.14.1 BUSINESS OVERVIEW
- 19.14.2 PRODUCT OFFERINGS
19.15 IHEALTHUNIFIEDCARE
- 19.15.1 BUSINESS OVERVIEW
- 19.15.2 PRODUCT OFFERINGS
19.16 QARDIO
- 19.16.1 BUSINESS OVERVIEW
- 19.16.2 PRODUCT OFFERING
19.17 MEDM
- 19.17.1 BUSINESS OVERVIEW
- 19.17.2 PRODUCT OFFERING
19.18 MASIMO CORPORATION
- 19.18.1 BUSINESS OVERVIEW
- 19.18.2 PRODUCT OFFERINGS
19.19 MEDOPAD
- 19.19.1 BUSINESS OVERVIEW
- 19.19.2 PRODUCT OFFERINGS
19.20 NIHON KOHDEN
- 19.20.1 BUSINESS OVERVIEW
- 19.20.2 PRODUCT OFFERINGS
19.21 OMRON HEALTHCARE
- 19.21.1 BUSINESS OVERVIEW
- 19.21.2 PRODUCT OFFERINGS
19.22 OSPLABS
- 19.22.1 BUSINESS OVERVIEW
- 19.22.2 PRODUCT OFFERINGS
19.23 RESIDEO TECHNOLOGIES
- 19.23.1 BUSINESS OVERVIEW
- 19.23.2 .PRODUCT OFFERING
19.24 SMITHS MEDICAL
- 19.24.1 BUSINESS OVERVIEW
- 19.24.2 .PRODUCT OFFERINGS
19.25 SPACELABS HEALTHCARE
- 19.25.1 BUSINESS OVERVIEW
- 19.25.2 PRODUCT OFFERINGS
19.26 SENSEONICS
- 19.26.1 BUSINESS OVERVIEW
- 19.26.2 PRODUCT OFFERINGS
19.27 TELEMEDCARE
- 19.27.1 BUSINESS OVERVIEW
- 19.27.2 PRODUCT OFFERINGS
19.28 VITALCONNECT
- 19.28.1 PRODUCT OFFERINGS
19.29 VITLS
- 19.29.1 BUSINESS OVERVIEW
- 19.29.2 PRODUCT OFFERINGS
19.30 MODICARE
- 19.30.1 BUSINESS OVERVIEW
- 19.30.2 PRODUCT OFFERINGS
19.31 HILLROM
- 19.31.1 BUSINESS OVERVIEW
- 19.31.2 PRODUCT OFFERINGS
19.32 VIVIFY HEALTH
- 19.32.1 BUSINESS OVERVIEW
- 19.32.2 PRODUCT OFFERING
19.33 ACL DIGITAL
- 19.33.1 BUSINESS OVERVIEW
- 19.33.2 PRODUCT OFFERINGS
19.34 DEXCOM
- 19.34.1 BUSINESS OVERVIEW
- 19.34.2 PRODUCT OFFERING
19.35 IRHYTHM TECHNOLOGIES
- 19.35.1 BUSINESS OVERVIEW
- 19.35.2 PRODUCT OFFERING
19.36 VIVALINK
- 19.36.1 BUSINESS OVERVIEW
- 19.36.2 PRODUCT OFFERING
19.37 BIOBEAT
- 19.37.1 PRODUCT OFFERINGS
19.38 CAREVALIDATE
- 19.38.1 BUSINESS OVERVIEW
- 19.38.2 PRODUCT OFFERINGS
19.39 BIOFOURMIS
- 19.39.1 BUSINESS OVERVIEW
- 19.39.2 PRODUCT OFFERING
19.40 CAREMINDR
- 19.40.1 BUSINESS OVERVIEW
- 19.40.2 PRODUCT OFFERING
19.41 DATOS HEALTH
- 19.41.1 BUSINESS OVERVIEW
- 19.41.2 PRODUCT OFFERINGS

20 REPORT SUMMARY

20.1 KEY TAKEAWAYS
20.2 STRATEGIC RECOMMENDATIONS

21 QUANTITATIVE SUMMARY

21.1 MARKET BY COMPONENTS
- 21.1.1 MARKET BY DEVICES & SOFTWARE
- 21.1.2 MARKET BY CARDIAC MONITORING DEVICES
- 21.1.3 MARKET BY RESPIRATORY MONITORING DEVICES
21.2 MARKET BY APPLICATION
21.3 MARKET BY END USER

22 APPENDIX

22.1 ABBREVIATIONS